Late-onset NPM1 mutation in a MYC-amplified relapsed/ refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib

Jaramillo, S., Scherer, M., Szu-Tu, C., Beneyto-Calabuig, S., Müller-Tidow, C., Schlenk, R. F., … Pabst, C. (2024). Late-onset NPM1 mutation in a MYC-amplified relapsed/ refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib. Haematologica, 109(11), 3811–3815. https://doi.org/10.3324/haematol.2023.284922